DiaMedica Therapeutics Announces 75% Enrollment Milestone in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial
DiaMedica Therapeutics Inc DMAC
$6.15
▲ +0.82%
(+$0.05)
Open
$6.07
Prev Close
$6.10
Day Range
$6.01 – $6.19
52W Range
$3.48 – $10.42
Market Cap
$328.69M
Beta
1.02
EPS (TTM)
$-0.71
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2008-01-04 |
| Shares Out. | 53,880,000 |
| Website | diamedica.com/ ↗ |
| Phone | 17634965454 |
DiaMedica Therapeutics Inc is a publicly traded company under the ticker symbol DMAC on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-05-01)